Page last updated: 2024-10-28

hydroxychloroquine and Familial Hypokalemic Periodic Paralysis

hydroxychloroquine has been researched along with Familial Hypokalemic Periodic Paralysis in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research Excerpts

ExcerptRelevanceReference
"Although renal tubular acidosis (RTA), secondary to autoimmune interstitial nephritis, develops in a large proportion of patients with Sjögren's syndrome (SS), most of the subjects are asymptomatic."1.33A primary Sjögren's syndrome patient with distal renal tubular acidosis, who presented with symptoms of hypokalemic periodic paralysis: Report of a case study and review of the literature. ( Celik, Y; Gerenli, M; Pamuk, ON; Soy, M, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Soy, M1
Pamuk, ON1
Gerenli, M1
Celik, Y1

Other Studies

1 other study available for hydroxychloroquine and Familial Hypokalemic Periodic Paralysis

ArticleYear
A primary Sjögren's syndrome patient with distal renal tubular acidosis, who presented with symptoms of hypokalemic periodic paralysis: Report of a case study and review of the literature.
    Rheumatology international, 2005, Volume: 26, Issue:1

    Topics: Acidosis, Renal Tubular; Adult; Antirheumatic Agents; Diagnosis, Differential; Drug Therapy, Combina

2005